Initial Public Offering (IPO)

An initial public offering (IPO) is the transaction that turns a private company into a public one: shares are sold to investors for the first time and the stock begins trading on an exchange. The process runs on a schedule. The company files an S-1 registration statement with the SEC disclosing its financials, underwriters from investment banks set a price range and a share count, the roadshow pitches institutional investors, and the final price is set the night before the first trade. A quiet period restricts underwriter research for 25 days after the offering, and a lock-up, typically 180 days, prevents insiders from selling their shares.

The economics are the part retail investors feel. The offering price is allocated mostly to institutions and favored clients, so the first-day pop between the offering price and the opening trade is profit the public rarely collects. Research going back decades finds newly public companies underperform the broader market over the following three to five years, while first-day returns run hot in froth markets. Direct listings and SPACs are the alternative routes to public markets, and both skip the underwriting.

The sequence is contractual. The company selects underwriters and files the S-1 registration statement with the SEC, the document that discloses the financials the public will be trading on. Underwriters then set a price range and an initial share count, and the roadshow sends management to pitch institutional investors across a week or two. The book of demand builds, the final offer price is set the night before listing, and the stock opens for trading the next morning, usually at a price different from the offer.

The allocation decides who profits. The offering shares go largely to institutions and the underwriters' priority clients, and retail brokers rarely pass the offer price through, which means the gap between the offer price and the opening trade, the pop, is earned by the parties already inside. In hot markets the pops run large: the 2020 and 2021 class produced first-day moves above 100% for several names. In cold markets, offerings are postponed, priced below the range, or cancelled entirely.

The structure has exits built in. The quiet period bars underwriter research for 25 days, and the lock-up, commonly 180 days, stops insiders from selling into the first months, which makes the lock-up expiration the stock's first genuine supply event. Underwriters can exercise a greenshoe option to stabilize early trading, and the fees, typically 7% of proceeds on mid-size offerings, come out of the company's raise. Direct listings skip the underwriting and the new share issuance, and SPACs merge a shell company with a target instead, which is a different door into the same room.

The IPO matters to an American investor mostly as a warning about the entry price. The famous first-day gains are collected by the allocation list, not the public, and the public pays the pop. The longer-term record is worse: academic research dating to the 1990s finds newly public companies underperform the market over the following three to five years, after the novelty fades and the lock-ups expire. Buying the name on day one is buying the most-covered, most-hyped price the stock will ever carry.

I watched a colleague named Brent (yes, that Brent) buy an electric-vehicle maker at the open of its 2021 IPO because the first-day print was going vertical, and describe the position as his retirement fund. The stock fell roughly 80% from his entry within two years. The pop he paid for was the marketing, and the marketing was included in the price.

The highest-leverage thing most Americans can do is wait out the spectacle: let the lock-ups expire, let several quarters of earnings arrive as a public company, and then decide with a price-to-earnings ratio instead of a news cycle. The market will still be there. Project the entry with the investment calculator and check the valuation with the P/E ratio calculator.